712NewsBrands Eyeing Chinese Expats in Singapore to Fuel Sales Post-COVID-19
As retail sales steadily recover, Chinese Expats have renewed their strong shopping sentiment with 63% spending more post COVID-19: EternityX survey reveals....
- 694Wire Stories
Montréal Exchange Extends Trading Hours to Asia Pacific Time Zones
Canada’s Derivatives Exchange further expands global reach, syncing trading hours with Asia Pacific markets in support of growing investor demand MONTRÉAL–(BUSINESS WIRE)–Montréal...
- 769Wire Stories
Fusionex Signs MoU with Alliance Islamic Bank to Accelerate SMEs’ Halal Business Growth
PETALING JAYA, Malaysia–(BUSINESS WIRE)–#AllianceIslamicBank–Artificial Intelligence and Big Data technology market leader Fusionex recently signed an MoU with Alliance Islamic Bank Berhad to...
- 994Wire Stories
Rio Tinto to triple Weipa solar capacity and add battery storage to help power operations
MELBOURNE, Australia–(BUSINESS WIRE)–Rio Tinto has approved a new solar farm and battery storage at Weipa in Queensland, in a move that will...
- 899Wire Stories
Datopotamab Deruxtecan Shows Encouraging Tumor Response in Patients with Advanced Non-Small Cell Lung Cancer with Actionable Genomic Alterations
Sub-analysis of TROPION-PanTumor01 phase 1 trial of datopotamab deruxtecan featured as late-breaking Mini Oral presentation at ESMO TROPION-Lung05 phase 2 trial currently...
- 724Wire Stories
Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)
The approval marks the first time a monoclonal antibody treatment for COVID-19 received full approval to treat patients with COVID-19 The approval...
- 668Wire Stories
ENHERTU® Demonstrated Robust and Durable Tumor Response of 54.9% in Patients with HER2 Mutant Metastatic Non-Small Cell Lung Cancer
First HER2 directed therapy to show a strong tumor response in this population Data from HER2 mutant cohort of pivotal DESTINY-Lung01 phase...
- 703Wire Stories
Enfusion Files Registration Statement with SEC for Proposed Initial Public Offering
NEW YORK & LONDON & HONG KONG–(BUSINESS WIRE)–Enfusion, Inc. (“Enfusion”), a leading provider of cloud-based investment management software and services, today announced...
- 630Wire Stories
Metals Acquisition Corp. Announces the Separate Trading of its Shares of Class A Ordinary Shares and Redeemable Warrants Commencing September 20, 2021
FORT WORTH, Texas–(BUSINESS WIRE)–Metals Acquisition Corp. (NYSE: MTAL.U) (the “Company”) announced that, commencing September 20, 2021, holders of the units sold in...
- 801Wire Stories
ENHERTU® Demonstrated Clinically Meaningful and Durable Response in Patients with HER2 Positive Advanced Gastric Cancer in DESTINY-Gastric02 Phase 2 Trial
First ENHERTU trial in Western patients with gastric cancer Efficacy and safety results consistent with pivotal DESTINY-Gastric01 trial; will support ongoing discussions...
